Impact of Non-pharmaceutical Interventions on the Control of COVID-19 in Iran: A Mathematical Modeling Study

Document Type : Original Article


1 Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

2 Department of Biostatistics and Epidemiology, School of Public Health, Kerman University of Medical Sciences, Kerman, Iran

3 Department of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran

4 HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

5 Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK


During the first months of the coronavirus disease 2019 (COVID-19) pandemic, Iran reported high numbers of infections and deaths. In the following months, the burden of this infection decreased significantly, possibly due to the impact of a package of interventions. We modeled the dynamics of COVID-19 infection in Iran to quantify the impacts of these interventions.
We used a modified susceptible–exposed–infected–recovered (SEIR) model to model the COVID-19 epidemic in Iran, from January 21, 2020 to September 21, 2020. We estimated the 95% uncertainty intervals (UIs) using Markov chain Monte Carlo simulation. Under different scenarios, we assessed the effectiveness of non-pharmaceutical interventions (NPIs) including physical distancing measures and self-isolation. We also estimated the time-varying reproduction number (Rt), using our mathematical model and epidemiologic data.
If no NPIs were applied, there could have been a cumulative number of 51 800 000 (95% UI: 1 910 000–77 600 000) COVID-19 infections and 266 000 (95% UI: 119 000–476 000) deaths by September 21, 2020. If physical distancing interventions, such as school/border closures and self-isolation interventions had been introduced a week earlier than they were actually launched, 30.8% and 35.2% reduction in the number of deaths and infections respectively could have been achieved by September 21, 2020. The observed daily number of deaths showed that the Rt was one or more than one almost every day during the analysis period.
Our models suggest that the NPIs implemented in Iran between January 21, 2020 and September 21, 2020 had significant effects on the spread of the COVID-19 epidemic. Our study also showed that the timely implementation of NPIs showed a profound effect on further reductions in the numbers of infections and deaths. This highlights the importance of forecasting and early detection of future waves of infection and of the need for effective preparedness and response capabilities.


Main Subjects

  1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733. doi:10.1056/NEJMoa2001017
  2. World Health Organization. Coronavirus disease (COVID-19) pandemic.Available from: Accessed November 27, 2020.
  3. Times NY. Iran reports its first 2 cases of the new coronavirus.Available from: Accessed May 9, 2020.
  4. Arab-Mazar Z, Sah R, Rabaan AA, Dhama K, Rodriguez-Morales AJ. Mapping the incidence of the COVID-19 hotspot in Iran - Implications for Travellers. Travel Med Infect Dis. 2020;34:101630. doi:10.1016/j.tmaid.2020.101630
  5. CDC NCoC-EaI. Analysis of epidemic trend by provinces of Iran. Available from: Accessed September 19, 2020.
  6. COVID-19 Coronavirus. Available from: Accessed September 19, 2020.
  7. National Committee on COVID-19 Epidemiology and Iranian CDC - Ministry of Health and Medical Education II. Major interventions to control COVID-19 from 19 Feb. Available from: Accessed March 15, 2020.
  8. Abdi M. Coronavirus disease 2019 (COVID-19) outbreak in Iran: actions and problems. Infect Control Hosp Epidemiol. 2020;41(6):754-755. doi:10.1017/ice.2020.86
  9. Davies NG, Kucharski AJ, Eggo RM, Gimma A, Edmunds WJ. Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study. Lancet Public Health. 2020;5(7):e375-e385. doi:10.1016/s2468-2667(20)30133-x
  10. Yang J, Zhang Q, Cao Z, et al. The impact of non-pharmaceutical interventions on the prevention and control of COVID-19 in New York City. Chaos. 2021;31(2):021101. doi:10.1063/5.0040560
  11. Lai S, Ruktanonchai NW, Zhou L, et al. Effect of non-pharmaceutical interventions to contain COVID-19 in China. Nature. 2020;585(7825):410-413. doi:10.1038/s41586-020-2293-x
  12. Bo Y, Guo C, Lin C, et al. Effectiveness of non-pharmaceutical interventions on COVID-19 transmission in 190 countries from 23 January to 13 April 2020. Int J Infect Dis. 2021;102:247-253. doi:10.1016/j.ijid.2020.10.066
  13. Ngonghala CN, Iboi E, Eikenberry S, et al. Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel coronavirus. Math Biosci. 2020;325:108364. doi:10.1016/j.mbs.2020.108364
  14. Hens N, Vranck P, Molenberghs G. The COVID-19 epidemic, its mortality, and the role of non-pharmaceutical interventions. Eur Heart J Acute Cardiovasc Care. 2020;9(3):204-208. doi:10.1177/2048872620924922
  15. Childs ML, Kain MP, Kirk D, et al. The impact of long-term non-pharmaceutical interventions on COVID-19 epidemic dynamics and control. medRxiv. 2020. doi:10.1101/2020.05.03.20089078
  16. Awaidy SA, Mahomed O. Impact of non-pharmaceutical interventions on the COVID-19 epidemic: a modelling study. SAGE Open Med. 2020;8:2050312120979462. doi:10.1177/2050312120979462
  17. Bajiya VP, Bugalia S, Tripathi JP. Mathematical modeling of COVID-19: impact of non-pharmaceutical interventions in India. Chaos. 2020;30(11):113143. doi:10.1063/5.0021353
  18. Sharifi H, Jahani Y, Mirzazadeh A, et al. Estimating COVID-19-related infections, deaths, and hospitalizations in Iran under different physical distancing and isolation scenarios. Int J Health Policy Manag. 2020. doi:10.34172/ijhpm.2020.134
  19. Moriyama M, Hugentobler WJ, Iwasaki A. Seasonality of respiratory viral infections. Annu Rev Virol. 2020;7(1):83-101. doi:10.1146/annurev-virology-012420-022445
  20. Petersen E, Koopmans M, Go U, et al. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis. 2020;20(9):e238-e244. doi:10.1016/s1473-3099(20)30484-9
  21. Shi P, Dong Y, Yan H, et al. Impact of temperature on the dynamics of the COVID-19 outbreak in China. Sci Total Environ. 2020;728:138890. doi:10.1016/j.scitotenv.2020.138890
  22. Khalili M, Karamouzian M, Nasiri N, Javadi S, Mirzazadeh A, Sharifi H. Epidemiological characteristics of COVID-19: a systematic review and meta-analysis. Epidemiol Infect. 2020;148:e130. doi:10.1017/s0950268820001430
  23. Kucharski AJ, Russell TW, Diamond C, et al. Early dynamics of transmission and control of COVID-19: a mathematical modelling study. Lancet Infect Dis. 2020;20(5):553-558. doi:10.1016/s1473-3099(20)30144-4
  24. You C, Deng Y, Hu W, et al. Estimation of the time-varying reproduction number of COVID-19 outbreak in China. Int J Hyg Environ Health. 2020;228:113555. doi:10.1016/j.ijheh.2020.113555
  25. Aghaali M, Kolifarhood G, Nikbakht R, Mozafar Saadati H, Hashemi Nazari SS. Estimation of the serial interval and basic reproduction number of COVID-19 in Qom, Iran, and three other countries: a data-driven analysis in the early phase of the outbreak. Transbound Emerg Dis. 2020;67(6):2860-2868. doi:10.1111/tbed.13656
  26. COVID-19: Disrupting lives, economies and societies. Available from: Accessed April 1, 2020.
  27. Nicola M, Alsafi Z, Sohrabi C, et al. The socio-economic implications of the coronavirus pandemic (COVID-19): a review. Int J Surg. 2020;78:185-193. doi:10.1016/j.ijsu.2020.04.018
  28. Zhang J, Litvinova M, Liang Y, et al. Age profile of susceptibility, mixing, and social distancing shape the dynamics of the novel coronavirus disease 2019 outbreak in China. medRxiv. 2020. doi:10.1101/2020.03.19.20039107
  29. Jarvis CI, Van Zandvoort K, Gimma A, et al. Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK. BMC Med. 2020;18(1):124. doi:10.1186/s12916-020-01597-8
  30. Khosravi A, Chaman R, Rohani-Rasaf M, Zare F, Mehravaran S, Emamian MH. The basic reproduction number and prediction of the epidemic size of the novel coronavirus (COVID-19) in Shahroud, Iran. Epidemiol Infect. 2020;148:e115. doi:10.1017/s0950268820001247
  31. He X, Lau EHY, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26(5):672-675. doi:10.1038/s41591-020-0869-5
  32. Tindale LC, Coombe M, Stockdale JE, et al. Transmission interval estimates suggest pre-symptomatic spread of COVID-19. medRxiv. 2020. doi:10.1101/2020.03.03.20029983
Volume 11, Issue 8
August 2022
Pages 1472-1481
  • Receive Date: 16 December 2020
  • Revise Date: 16 April 2021
  • Accept Date: 19 April 2021
  • First Publish Date: 09 June 2021